Showing results (381-390 of 470) with videos related to
Sort By:
Pageof 47
Clinical and Experimental Immunology|May 1, 1989
Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosisR M Hoffmann, G R Pape, U Spengler, et al.European Journal of Medical Research|May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infectionL Leifeld, J Rockstroh, S Skaide, et al.Nuklearmedizin. Nuclear Medicine|September 14, 2000
Liver perfusion scintigraphy prior to and after transjugular intrahepatic portosystemic shunts (TIPS) in patients with portal hypertensionP Willkomm, A Schomburg, K A Brensing, et al.The Journal of Pathology|August 28, 2001
Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitisL Leifeld, J Ramakers, A M Schneiders, et al.Cancer Investigation|October 2, 2001
Severe abdominal infections in neutropenic patientsM Gorschlüter, A Glasmacher, C Hahn, et al.Digestion|September 11, 2001
Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfectionU Düesberg, O Geulen, A M Schneiders, et al.Alimentary Pharmacology & Therapeutics|December 9, 2010
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinomaF Mihalache, A Höblinger, F Grünhage, et al.Zeitschrift Fur Gastroenterologie|October 1, 1996
[Libyan patient with chronic diarrhea]J Mezger, P Malfertheiner, A Glasmacher, et al.Journal of Immunological Methods|August 1, 2000
Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standardsF L Dumoulin, H D Nischalke, L Leifeld, et al.Scandinavian Journal of Gastroenterology|October 11, 2002
Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shuntK A Brensing, M Hörsch, J Textor, et al.Pageof 47